Foenumoside B from Lysimachia foenum-graecum inhibits adipocyte differentiation and obesity induced by high-fat diet

Biochemical and Biophysical Research Communications

Volumn 417, Issue 2, 2012, Pages 800-806

  Seo, Jong Bae ^a   Park, Sang Wook ^a   Choe, Sung Sik ^a   Jeong, Hyun Woo ^b   Park, Jae Young ^a   Choi, Eun Wook ^a   Seen, Dong Seung ^a   Jeong, Jae Yeon ^c   Lee, Tae Gyu ^a  

^a R and D Center   (South Korea)

^b Seoul National University   (South Korea)

^c Korea Research Institute of Ships and Ocean Engineering   (South Korea)

Author keywords

AMPK; Foenumoside B; High fat diet; Lysimachia foenum graecum; Obesity; PPAR

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOBESITY AGENT; ASPARTATE AMINOTRANSFERASE; FOENUMOSIDE B; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SAPONIN DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; IC 50; IN VITRO STUDY; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPOLYSIS; LIVER; LYSIMACHIA FOENUM GRAECUM; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTI-OBESITY AGENTS; DIET, HIGH-FAT; ENZYME ACTIVATION; GENE EXPRESSION; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; OBESITY; PRIMULACEAE; PROTEIN KINASES; SAPONINS;

LYSIMACHIA FOENUM-GRAECUM; MUS;

EID: 84855855566     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.039     Document Type: Article

References (18)

1. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
2. Lefterova M.I., Lazar M.A. New developments in adipogenesis. Trends Endocrinol. Metab. 2009, 20:107-114.
3. Fogarty S., Hardie D.G. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim. Biophys. Acta 2010, 1804:581-591.
4. Tilg H., Moschen A.R. Insulin resistance inflammation and non-alcoholic fatty liver disease. Trends Endocrinol. Metab. 2008, 19:371-379.
5. Powell A.G., Apovian C.M., Aronne L.J. New drug targets for the treatment of obesity. Clin. Pharmacol. Ther. 2011, 90:40-51.
6. Lee Y.K., Lee W.S., Hwang J.T., Kwon D.Y., Surh Y.J., Park O.J. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J. Agric. Food Chem. 2009, 57:305-310.
7. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., Ye J.M., Lee C.H., Oh W.K., Kim C.T., Hohnen-Behrens C., Gosby A., Kraegen E.W., James D.E., Kim J.B. Berberine, a natural plant productactivates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006, 55:2256-2264.
8. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., Wierzbicki M., Verbeuren T.J., Cohen R.A. Polyphenols stimulate AMP-activated protein kinase lower lipids and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55:2180-2191.
9. Shen Y.H., Weng Z.Y., Zhao Q.S., Zeng Y.Q., Rios J.L., Xiao W.L., Xu G., Sun H.D. Five new triterpene glycosides from Lysimachia foenum-graecum and evaluation of their effect on the arachidonic acid metabolizing enzyme. Planta Med. 2005, 71:770-775.
10. Seo J.B., Choe S.S., Jeong H.W., Park S.W., Shin H.J., Choi S.M., Park J.Y., Choi E.W., Kim J.B., Seen D.S., Jeong J.Y., Lee T.G. Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism. Exp. Mol. Med. 2011, 43:205-215.
11. Li X.R., Xin B., Wang G.L., Dai Z., Lin R.C. Two new triterpenes from Lysimachia foenum-graecum. J. Asian Nat. Prod. Res. 2010, 12:204-208.
12. Seo J.B., Moon H.M., Kim W.S., Lee Y.S., Jeong H.W., Yoo E.J., Ham J., Kang H., Park M.G., Steffensen K.R., Stulnig T.M., Gustafsson J.A., Park S.D., Kim J.B. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol. Cell. Biol. 2004, 24:3430-3444.
13. van Herpen N.A., Schrauwen-Hinderling V.B. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol. Behav. 2008, 94:231-241.
14. Ahmed M.H., Byrne C.D. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov. Today 2007, 12:740-747.
15. Frederico M.J., Vitto M.F., Cesconetto P.A., Engelmann J., De Souza D.R., Luz G., Pinho R.A., Ropelle E.R., Cintra D.E., De Souza C.T. Short-term inhibition of SREBP-1c expression reverses diet-induced non-alcoholic fatty liver disease in mice. Scand J. Gastroenterol. 2011, 46:1381-1388.
16. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 1995, 95:2409-2415.
17. Jhun B.S., Jin Q., Oh Y.T., Kim S.S., Kong Y., Cho Y.H., Ha J., Baik H.H., Kang I. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem. Biophys. Res. Commun. 2004, 318:372-380.
18. Sag D., Carling D., Stout R.D., Suttles J. Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 2008, 181:8633-8641.